Jin Medical CEO Outlines Strategic Priorities and Growth Plans in Fireside Chat

Reuters

Feb 10

Jin Medical CEO Outlines Strategic Priorities and Growth Plans in Fireside Chat

Jin Medical International Ltd. $(ZJYL)$, a leading provider of rehabilitation medical equipment, hosted a CEO Fireside Chat on February 2, 2026. During the session, CEO Dr. Erqi Wang discussed the company’s recent strategic priorities and long-term growth plans. Dr. Wang addressed topics such as the rationale behind the company’s recent reverse stock split proposal, emphasizing its role in both Nasdaq compliance and as a strategic reset to enhance capital structure and market perception. He also outlined Jin Medical’s commitment to clear market communication, disciplined capital allocation, and a long-term operational focus. Additionally, Dr. Wang highlighted the company's strategies for navigating industry evolution and managing geopolitical and supply chain risks, including supply chain diversification and regional manufacturing flexibility.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-013699), on February 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2610669431"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2610669431\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2610669431?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-10 05:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2610669431","market":"nz","top_or_hot":-1,"title":"Jin Medical CEO Outlines Strategic Priorities and Growth Plans in Fireside Chat","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Jin Medical CEO Outlines Strategic Priorities and Growth Plans in Fireside Chat\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Jin Medical International Ltd. <a href=\"https://laohu8.com/S/ZJYL\">$(ZJYL)$</a>, a leading provider of rehabilitation medical equipment, hosted a CEO Fireside Chat on February 2, 2026. During the session, CEO Dr. Erqi Wang discussed the company’s recent strategic priorities and long-term growth plans. Dr. Wang addressed topics such as the rationale behind the company’s recent reverse stock split proposal, emphasizing its role in both Nasdaq compliance and as a strategic reset to enhance capital structure and market perception. He also outlined Jin Medical’s commitment to clear market communication, disciplined capital allocation, and a long-term operational focus. Additionally, Dr. Wang highlighted the company's strategies for navigating industry evolution and managing geopolitical and supply chain risks, including supply chain diversification and regional manufacturing flexibility.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-013699), on February 09, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jin Medical CEO Outlines Strategic Priorities and Growth Plans in Fireside Chat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJin Medical CEO Outlines Strategic Priorities and Growth Plans in Fireside Chat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-10 05:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Jin Medical CEO Outlines Strategic Priorities and Growth Plans in Fireside Chat\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Jin Medical International Ltd. <a href=\"https://laohu8.com/S/ZJYL\">$(ZJYL)$</a>, a leading provider of rehabilitation medical equipment, hosted a CEO Fireside Chat on February 2, 2026. During the session, CEO Dr. Erqi Wang discussed the company’s recent strategic priorities and long-term growth plans. Dr. Wang addressed topics such as the rationale behind the company’s recent reverse stock split proposal, emphasizing its role in both Nasdaq compliance and as a strategic reset to enhance capital structure and market perception. He also outlined Jin Medical’s commitment to clear market communication, disciplined capital allocation, and a long-term operational focus. Additionally, Dr. Wang highlighted the company's strategies for navigating industry evolution and managing geopolitical and supply chain risks, including supply chain diversification and regional manufacturing flexibility.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-013699), on February 09, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZJYL","symbol_name":"中进医疗","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL79BY5C:1","article_id":"2610669431","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2610669431","pubTimestamp":1770673270,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Jin Medical International Ltd. , a leading provider of rehabilitation medical equipment, hosted a CEO Fireside Chat on February 2, 2026. During the session, CEO Dr. Erqi Wang discussed the company’s recent strategic priorities and long-term growth plans. Dr. Wang addressed topics such as the rationale behind the company’s recent reverse stock split proposal, emphasizing its role in both Nasdaq compliance and as a strategic reset to enhance capital structure and market perception. He also outlined Jin Medical’s commitment to clear market communication, disciplined capital allocation, and a long-term operational focus. Additionally, Dr. Wang highlighted the company's strategies for navigating industry evolution and managing geopolitical and supply chain risks, including supply chain diversification and regional manufacturing flexibility.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ZJYL":"中进医疗","BK4082":"医疗保健设备"},"translate_title":"金医疗首席执行官炉边谈话概述战略重点和增长计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZJYL":0.9},"content_text":"Jin Medical CEO Outlines Strategic Priorities and Growth Plans in Fireside Chat\n    \n\n        Jin Medical International Ltd. $(ZJYL)$, a leading provider of rehabilitation medical equipment, hosted a CEO Fireside Chat on February 2, 2026. During the session, CEO Dr. Erqi Wang discussed the company’s recent strategic priorities and long-term growth plans. Dr. Wang addressed topics such as the rationale behind the company’s recent reverse stock split proposal, emphasizing its role in both Nasdaq compliance and as a strategic reset to enhance capital structure and market perception. He also outlined Jin Medical’s commitment to clear market communication, disciplined capital allocation, and a long-term operational focus. Additionally, Dr. Wang highlighted the company's strategies for navigating industry evolution and managing geopolitical and supply chain risks, including supply chain diversification and regional manufacturing flexibility.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-013699), on February 09, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}